EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Anti-inflammatory Effect of Batroxobin Combined With Anticoagulation in Patients With Cerebral Venous Thrombosis

Duo Lan, Xiaoming Zhang, Xiangqian Huang, Jingrun Li, Jiahao Song, Da Zhou, Ran Meng iD

Clinical and Applied Thrombosis/Hemostasis · 2024-01 · 30

DOI: 10.1177/10760296241264516 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Applied Thrombosis/Hemostasis, online erschienen am 21.07.2024. Verfasst von Duo Lan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: Batroxobin, Anticoagulants, Venous Thrombosis, Intracranial Thrombosis. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Inflammation is pivotal in the pathogenesis and development of cerebral venous thrombosis (CVT). Herein, we aimed to assess the anti-inflammatory effects of batroxobin combined with anticoagulation in CVT. Participants were categorized into the batroxobin group (batroxobin combined with anticoagulation) and the control group (anticoagulation only). Regression analysis was employed to explore the association between the number of episodes of batroxobin administration and the fluctuation of inflammatory indicators, as well as the proportion of patients with inflammatory indicators that were reduced after batroxobin use. Twenty-three cases (age: 39.9 ± 13.8 years, female: 39.1%) in the batroxobin group and 36 cases (40.3 ± 9.6 years, 52.8%) in the control group were analyzed. Compared to the control group, batroxobin combined with anticoagulation significantly decreased fibrinogen ( P < .001), platelet–lymphocyte ratio (PLR) ( P = .016) and systemic immune–inflammation index (SII) ( P = .008), and increased the proportion of the patients with lower fibrinogen ( P < .001), neutrophil–lymphocyte ratio (NLR) ( P = .005), PLR ( P = .026), and SII ( P = .006). Linear analysis showed that as the number of episodes of batroxobin administration increased, the fibrinogen ( P < .001), the PLR ( P = .001), and the SII ( P = .020) significantly decreased. Logistic regression analysis showed as the number of episodes of batroxobin administration increased, the ratio of the patients with decreased NLR ( P = .008) and PLR ( P = .015), as well as SII ( P = .013), significantly increased. Batroxobin could decrease NLR, PLR, and SII in CVT. The effect was related to the number of episodes of batroxobin administration. Besides reducing fibrinogen and indirect thrombolysis effects, this may be another critical benefit of batroxobin for CVT.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BatroxobinAnticoagulantsVenous ThrombosisIntracranial ThrombosisHumansFemaleMaleAdultMiddle AgedAnti-Inflammatory Agents

Stichwörter der Autor:innen

anti-inflammationanticoagulationbatroxobincerebral venous thrombosisplatelet–lymphocyte ratiosystemic immune–inflammation index

Substanzen

BatroxobinAnticoagulantsAnti-Inflammatory Agents

Autor:innen und Institutionen

  • Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China.
  • Advanced Center of Stroke, Beijing Institute for Brain Disorders, Beijing, China.

ORCID-Profile: Ran Meng

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Lan, D., Zhang, X., Huang, X., Li, J., Song, J., Zhou, D., & Meng, R. (2024). Anti-inflammatory Effect of Batroxobin Combined With Anticoagulation in Patients With Cerebral Venous Thrombosis. Clinical and Applied Thrombosis/Hemostasis, 30. https://doi.org/10.1177/10760296241264516

Vancouver

Lan D, Zhang X, Huang X, Li J, Song J, Zhou D, et al. Anti-inflammatory Effect of Batroxobin Combined With Anticoagulation in Patients With Cerebral Venous Thrombosis. Clinical and Applied Thrombosis/Hemostasis. 2024;30. doi:10.1177/10760296241264516

BibTeX
@article{Lan2024,
  author = {Lan, Duo and Zhang, Xiaoming and Huang, Xiangqian and Li, Jingrun and Song, Jiahao and Zhou, Da and Meng, Ran},
  title = {Anti-inflammatory Effect of Batroxobin Combined With Anticoagulation in Patients With Cerebral Venous Thrombosis},
  journal = {Clinical and Applied Thrombosis/Hemostasis},
  year = {2024},
  volume = {30},
  doi = {10.1177/10760296241264516}
}
Kostenlos starten →